Is China the pharmaceutical industry’s greatest opportunity for growth?

How does China compare against other identified emerging markets such as India? Important issues such as conformity to global standards, regulatory environment, future potential for in-market sales, and protection of intellectual property are the criterion from which the pharmaceutical industry is measuring their level of potential investment.

“IMPACT CHINA: Pharmaceutical R&D Global Summit” will explore these issues and shed light on why many regard China as the next frontier for the pharmaceutical industry. Taking place in Shanghai, the burgeoning region for China’s pharmaceutical industry, this groundbreaking event lends a platform for the scientific and business leaders in the pharmaceutical industry to discuss the opportunities and challenges ahead in the rapidly developing Chinese market.